Highlights AViTA Corporation

Equities

4735

TW0004735006

End-of-day quote Taipei Exchange Other stock markets 23:00:00 14/05/2024 BST			5-day change	1st Jan Change
35.2 ^TWD	-0.28%		-0.56%	-4.22%

05-14	Avita Medical Widens Q1 Loss as Sales, Marketing Expense Jumps; Shares Up 10%	MT
04-12	North American Morning Briefing : Big Banks Kick -2-	DJ

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avita Medical Widens Q1 Loss as Sales, Marketing Expense Jumps; Shares Up 10%	05-14	MT
Avita Medical Lowers Q1 Revenue Guidance on Slower New Account Approvals	04-11	MT
AViTA Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday on Expected Rate Cut Trajectory Insights	01-11	MT
Avita Medical Signs US Distribution Agreement for Wound Healing Products	01-11	MT
Avita Medical Signs Deal with Stedical Scientific for US Distribution of PermeaDerm	01-11	MT
Avita Medical Lowers Guidance for 2023 Commercial Revenue	11-20	MT
AViTA Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Avita Medical Widens Q3 Loss as Sales, Marketing Costs Rise; Shares Climb 17%	11-10	MT
AVITA Medical Logs 50% Jump in Q3 Revenue; Maintains 2023 Guidance	19/10/23	MT
AViTA Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23	CI
Avita Medical Widens Fiscal Q2 Loss on Higher Marketing Costs; Shares Rise 3%	11/08/23	MT
Avita Medical Files US FDA Pre-Market Supplement Application for Skin Harvesting Device	30/06/23	MT
Rising Yields in Focus Amid Muted Exchange-Traded Funds, Equity Futures Pre-Bell Thursday	08/06/23	MT
Avita Medical Secures US FDA Approval for Skin Restoration System	08/06/23	MT
AViTA Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Avita Medical Says Treatment for Acute Wounds Maintains FDA's Breakthrough Device Designation	14/04/23	MT
Avita Medical's Automated Device Maintains US FDA Breakthrough Device Designation	14/04/23	MT
Avita Medical Files Vitiligo Indication for Skin Restoration Therapy with US FDA; Shares Fall 5%	19/12/22	MT
Avita Medical Applies to FDA to Expand Use of RECELL System to Include Soft Tissue Repair	12/12/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AViTA Corporation

Equities

4735

TW0004735006

Highlights

Filters